These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 11210555)

  • 1. Biological properties and measurement of phospholipase D activation by ADP-ribosylation factor (ARF).
    Cockcroft S; Bi K; Ktistakis NT; Roth MG
    Methods Enzymol; 2001; 329():355-72. PubMed ID: 11210555
    [No Abstract]   [Full Text] [Related]  

  • 2. Activation of exocytosis by cross-linking of the IgE receptor is dependent on ADP-ribosylation factor 1-regulated phospholipase D in RBL-2H3 mast cells: evidence that the mechanism of activation is via regulation of phosphatidylinositol 4,5-bisphosphate synthesis.
    Way G; O'luanaigh N; Cockcroft S
    Biochem J; 2000 Feb; 346 Pt 1(Pt 1):63-70. PubMed ID: 10657240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous phospholipase D2 localizes to the plasma membrane of RBL-2H3 mast cells and can be distinguished from ADP ribosylation factor-stimulated phospholipase D1 activity by its specific sensitivity to oleic acid.
    Sarri E; Pardo R; Fensome-Green A; Cockcroft S
    Biochem J; 2003 Jan; 369(Pt 2):319-29. PubMed ID: 12374567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of activated ADP-ribosylation factors on Golgi morphology require neither activation of phospholipase D1 nor recruitment of coatomer.
    Kuai J; Boman AL; Arnold RS; Zhu X; Kahn RA
    J Biol Chem; 2000 Feb; 275(6):4022-32. PubMed ID: 10660559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phospholipase D: a downstream effector of ARF in granulocytes.
    Cockcroft S; Thomas GM; Fensome A; Geny B; Cunningham E; Gout I; Hiles I; Totty NF; Truong O; Hsuan JJ
    Science; 1994 Jan; 263(5146):523-6. PubMed ID: 8290961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ADP-ribosylation factor 4 small GTPase mediates epidermal growth factor receptor-dependent phospholipase D2 activation.
    Kim SW; Hayashi M; Lo JF; Yang Y; Yoo JS; Lee JD
    J Biol Chem; 2003 Jan; 278(4):2661-8. PubMed ID: 12446727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ADP ribosylation factor 1 mutants identify a phospholipase D effector region and reveal that phospholipase D participates in lysosomal secretion but is not sufficient for recruitment of coatomer I.
    Jones DH; Bax B; Fensome A; Cockcroft S
    Biochem J; 1999 Jul; 341 ( Pt 1)(Pt 1):185-92. PubMed ID: 10377261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium-regulated exocytosis of dense-core vesicles requires the activation of ADP-ribosylation factor (ARF)6 by ARF nucleotide binding site opener at the plasma membrane.
    Vitale N; Chasserot-Golaz S; Bailly Y; Morinaga N; Frohman MA; Bader MF
    J Cell Biol; 2002 Oct; 159(1):79-89. PubMed ID: 12379803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ARF proteins mediate insulin-dependent activation of phospholipase D.
    Shome K; Vasudevan C; Romero G
    Curr Biol; 1997 Jun; 7(6):387-96. PubMed ID: 9197239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reconstitution of GTP-gamma-S-dependent phospholipase D activity with ARF, RhoA, and a soluble 36-kDa protein.
    Shimooku K; Akisue T; Jinnai H; Hitomi T; Ogino C; Yoshida K; Nakamura S; Nishizuka Y
    FEBS Lett; 1996 Jun; 387(2-3):141-4. PubMed ID: 8674536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role and regulation of phospholipase D activity in normal and cancer cells.
    Wakelam MJ; Martin A; Hodgkin MN; Brown F; Pettitt TR; Cross MJ; De Takats PG; Reynolds JL
    Adv Enzyme Regul; 1997; 37():29-34. PubMed ID: 9381975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phospholipase D is present on Golgi-enriched membranes and its activation by ADP ribosylation factor is sensitive to brefeldin A.
    Ktistakis NT; Brown HA; Sternweis PC; Roth MG
    Proc Natl Acad Sci U S A; 1995 May; 92(11):4952-6. PubMed ID: 7761430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ADP-ribosylation factor, a small GTP-dependent regulatory protein, stimulates phospholipase D activity.
    Brown HA; Gutowski S; Moomaw CR; Slaughter C; Sternweis PC
    Cell; 1993 Dec; 75(6):1137-44. PubMed ID: 8261513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ADP-ribosylation factor 1-regulated phospholipase D activity is localized at the plasma membrane and intracellular organelles in HL60 cells.
    Whatmore J; Morgan CP; Cunningham E; Collison KS; Willison KR; Cockcroft S
    Biochem J; 1996 Dec; 320 ( Pt 3)(Pt 3):785-94. PubMed ID: 9003363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-permeable ceramides preferentially inhibit coated vesicle formation and exocytosis in Chinese hamster ovary compared with Madin-Darby canine kidney cells by preventing the membrane association of ADP-ribosylation factor.
    Abousalham A; Hobman TC; Dewald J; Garbutt M; Brindley DN
    Biochem J; 2002 Feb; 361(Pt 3):653-61. PubMed ID: 11802796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphatidylinositol 4-phosphate 5-kinase alpha is a downstream effector of the small G protein ARF6 in membrane ruffle formation.
    Honda A; Nogami M; Yokozeki T; Yamazaki M; Nakamura H; Watanabe H; Kawamoto K; Nakayama K; Morris AJ; Frohman MA; Kanaho Y
    Cell; 1999 Nov; 99(5):521-32. PubMed ID: 10589680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ARF-directed guanine-nucleotide-exchange (GEP) proteins.
    Pacheco-Rodriguez G; Moss J; Vaughan M
    Methods Mol Biol; 2002; 189():181-9. PubMed ID: 12094586
    [No Abstract]   [Full Text] [Related]  

  • 18. BIG1 and BIG2: brefeldin A-inhibited guanine nucleotide-exchange proteins for ADP-ribosylation factors.
    Pacheco-Rodriguez G; Moss J; Vaughan M
    Methods Enzymol; 2002; 345():397-404. PubMed ID: 11665623
    [No Abstract]   [Full Text] [Related]  

  • 19. Exocytosis of CTLA-4 is dependent on phospholipase D and ADP ribosylation factor-1 and stimulated during activation of regulatory T cells.
    Mead KI; Zheng Y; Manzotti CN; Perry LC; Liu MK; Burke F; Powner DJ; Wakelam MJ; Sansom DM
    J Immunol; 2005 Apr; 174(8):4803-11. PubMed ID: 15814706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ADP-ribosylation factor-dependent phospholipase D activation by VPAC receptors and a PAC(1) receptor splice variant.
    McCulloch DA; Lutz EM; Johnson MS; Robertson DN; MacKenzie CJ; Holland PJ; Mitchell R
    Mol Pharmacol; 2001 Jun; 59(6):1523-32. PubMed ID: 11353814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.